Sus causas, fisiopatología y tratamiento actual | 01 SEP 18

Enfermedades pleurales

Revisión en profundidad sobre diversos aspectos de la enfermedad pleural
Autor/a: David Feller Kopman, Richard Light N Engl J Med 2018;378:740-51
INDICE:  1. Página 1 | 2. Referencias bibliográficas
Referencias bibliográficas

1. Light R. Pleural disease. 6th ed. Philadelphia: Lippincott Williams & Wilkins, 2013.

2. Agostoni E. Mechanics of the pleural space. Physiol Rev 1972; 52: 57-128.

3. Lai-Fook SJ. Pleural mechanics and fluid exchange. Physiol Rev 2004; 84: 385-410.

4. Wang NS. Anatomy of the pleura. Clin Chest Med 1998; 19: 229-40.

5. West JB. Why doesn’t the elephant have a pleural space? News Physiol Sci 2002; 17: 47-50.

6. West JB. Snorkel breathing in the elephant explains the unique anatomy of its pleura. Respir Physiol 2001; 126: 1-8.

7. Grathwohl KW, Derdak S. Buffalo chest. N Engl J Med 2003; 349: 1829.

8. Stathopoulos GT, Moschos C, Loutrari H, et al. Zoledronic acid is effective against experimental malignant pleural effusion. Am J Respir Crit Care Med 2008;178: 50-9.

9. Psallidas I, Kalomenidis I, Porcel JM, Robinson BW, Stathopoulos GT. Malignant pleural effusion: from bench to bedside. Eur Respir Rev 2016; 25: 189-98.

10. Agostoni E, D’Angelo E. Thickness and pressure of the pleural liquid at varios heights and with various hydrothoraces. Respir Physiol 1969; 6: 330-42.

11. Noppen M, De Waele M, Li R, et al. Volume and cellular content of normal pleural fluid in humans examined by pleural lavage. Am J Respir Crit Care Med 2000; 162: 1023-6.

12. Miserocchi G. Physiology and pathophysiology of pleural fluid turnover. Eur Respir J 1997; 10: 219-25.

13. Ashbaugh DG. Empyema thoracis: factors influencing morbidity and mortality. Chest 1991; 99: 1162-5.

14. Kohan JM, Poe RH, Israel RH, et al. Value of chest ultrasonography versus decubitus roentgenography for thoracentesis. Am Rev Respir Dis 1986; 133: 1124-6.

15. Diacon AH, Brutsche MH, Soler M. Accuracy of pleural puncture sites: a prospective comparison of clinical examination with ultrasound. Chest 2003; 123: 436-41.

16. Eibenberger KL, Dock WI, Ammann ME, Dorffner R, Hormann MF, Grabenwoger F. Quantification of pleural effusions: sonography versus radiography. Radiology 1994; 191: 681-4.

17. Grogan DR, Irwin RS, Channick R, et al. Complications associated with thoracentesis: a prospective, randomized study comparing three different methods. Arch Intern Med 1990; 150: 873-7.

18. Yang PC, Luh KT, Chang DB, Wu HD, Yu CJ, Kuo SH. Value of sonography in determining the nature of pleural effusion: analysis of 320 cases. AJR Am J Roentgenol 1992; 159: 29-33.

19. Qureshi NR, Rahman NM, Gleeson FV. Thoracic ultrasound in the diagnosis of malignant pleural effusion. Thorax 2009; 64: 139-43.

20. Gordon CE, Feller-Kopman D, Balk EM, Smetana GW. Pneumothorax following thoracentesis: a systematic review and meta-analysis. Arch Intern Med 2010; 170: 332-9.

21. Hooper C, Lee YCG, Maskell N. Investigation of a unilateral pleural effusion in adults: British Thoracic Society Pleural Disease Guideline 2010. Thorax 2010; 65: Suppl 2: ii4-ii17.

22. Havelock T, Teoh R, Laws D, Gleeson F. Pleural procedures and thoracic ultrasound: British Thoracic Society Pleural Disease Guideline 2010. Thorax 2010; 65:Suppl 2: ii61-ii76.

23. Hooper CE, Lee YC, Maskell NA. Setting up a specialist pleural disease service. Respirology 2010; 15: 1028-36. 24. Paddock FK. The diagnostic significance of serous fluids in disease. N Engl J

Med 1940; 223: 1010-5.

25. Light RW, Macgregor MI, Luchsinger PC, Ball WC Jr. Pleural effusions: the diagnostic separation of transudates and exudates. Ann Intern Med 1972; 77: 507-13.

26. Heffner JE, Brown LK, Barbieri CA. Diagnostic value of tests that discriminate between exudative and transudative pleural effusions. Chest 1997; 111: 970-80.

27. Romero-Candeira S, Fernandez C, Martin C, Sanchez-Paya J, Hernandez L. Influence of diuretics on the concentration of proteins and other components of pleural transudates in patients with heart failure. Am J Med 2001; 110: 681-6.

28. Romero-Candeira S, Hernandez L, Romero-Brufao S, Orts D, Fernandez C, Martin C. Is it meaningful to use biochemical parameters to discriminate between transudative and exudative pleural effusions? Chest 2002; 122: 1524-9.

29. Bielsa S, Porcel JM, Castellote J, Mas E, Esquerda A, Light RW. Solving the Light’s criteria misclassification rate of cardiac and hepatic transudates. Respirology 2012; 17: 721-6.

30. Porcel JM, Vives M, Cao G, Esquerda A, Rubio M, Rivas MC. Measurement of pro-brain natriuretic peptide in pleural fluid for the diagnosis of pleural effusions due to heart failure. Am J Med 2004; 116: 417-0.

31. Kolditz M, Halank M, Schiemanck CS, Schmeisser A, Hoffken G. High diagnostic accuracy of NT-proBNP for cardiac origin of pleural effusions. Eur Respir J 2006; 28: 144-50.

32. Carr DT, Power MH. Clinical value of measurements of concentration of protein in pleural fluid. N Engl J Med 1958;259: 926-7.

33. Costa M, Quiroga T, Cruz E. Measurement of pleural fluid cholesterol and lactate dehydrogenase: a simple and accurate set of indicators for separating exudates from transudates. Chest 1995; 108: 1260-3.

34. Porcel JM, Vives M, Vicente de Vera MC, Cao G, Rubio M, Rivas MC. Useful tests on pleural fluid that distinguish transudates from exudates. Ann Clin Biochem 2001; 38: 671-5.

35. Internet Classics Archive. Aphorisms by Hippocrates (Adams F, translator) (http://classics .mit .edu/ Hippocrates/ aphorisms .mb .txt).

36. Adams F. The genuine works of Hippocrates. London: C. and J. Adlard Printers, 1848.

37. Hasley PB, Albaum MN, Li YH, et al. Do pulmonary radiographic findings at presentation predict mortality in patients with community-acquired pneumonia? Arch Intern Med 1996; 156: 2206-12.

38. Menendez R, Torres A, Zalacain R, et al. Risk factors of treatment failure in community acquired pneumonia: implications for disease outcome. Thorax 2004; 59: 960-5.

39. Grijalva CG, Zhu Y, Nuorti JP, Griffin MR. Emergence of parapneumonic empiema in the USA. Thorax 2011; 66: 663-8.

40. Bender JM, Ampofo K, Sheng X, Pavia AT, Cannon-Albright L, Byington CL. Parapneumonic empyema deaths during past century, Utah. Emerg Infect Dis 2009; 15:44-8.

41. El Solh AA, Alhajjhasan A, Ramadan FH, Pineda LA. A comparative study of community- and nursing home-acquired empyema thoracis. J Am Geriatr Soc 2007;55: 1847-52.

42. Maskell NA, Batt S, Hedley EL, Davies CW, Gillespie SH, Davies RJ. The bacteriology of pleural infection by genetic and standard methods and its mortality significance. Am J Respir Crit Care Med 2006; 174: 817-23.

43. Rahman NM, Kahan BC, Miller RF, Gleeson FV, Nunn AJ, Maskell NA. A clinical score (RAPID) to identify those at risk for poor outcome at presentation in patients with pleural infection. Chest 2014;145: 848-55.

44. Davies HE, Davies RJO, Davies CWH. Management of pleural infection in adults: British Thoracic Society Pleural Disease Guideline 2010. Thorax 2010; 65: Suppl 2:ii41-ii53.

45. Rahman NM, Maskell NA, Davies CWH, et al. The relationship between chest tube size and clinical outcome in pleural infection. Chest 2010; 137: 536-43. 46. Keeling AN, Leong S, Logan PM, Lee MJ. Empyema and effusion: outcome of image-guided small-bore catheter drainage. Cardiovasc Intervent Radiol 2008; 31:135-41.

47. Rahman NM, Maskell NA, West A, et al. Intrapleural use of tissue plasminogen activator and DNase in pleural infection. N Engl J Med 2011; 365: 518-26.

48. Wait MA, Sharma S, Hohn J, Dal Nogare A. A randomized trial of empiema therapy. Chest 1997; 111: 1548-51.

 

Comentarios

Para ver los comentarios de sus colegas o para expresar su opinión debe ingresar con su cuenta de IntraMed.

AAIP RNBD
Términos y condiciones de uso | Política de privacidad | Todos los derechos reservados | Copyright 1997-2024